Shares of Option Care Health, Inc. (NASDAQ:OPCH - Get Free Report) have earned an average recommendation of "Moderate Buy" from the fourteen analysts that are covering the company, Marketbeat Ratings reports. Seven research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average 1-year target price among brokers that have updated their coverage on the stock in the last year is $29.92.
OPCH has been the topic of a number of recent research reports. UBS Group restated a "buy" rating on shares of Option Care Health in a research note on Tuesday, September 22nd. Zacks Research upgraded Option Care Health from a "strong sell" rating to a "hold" rating in a research report on Monday, July 6th. Wall Street Zen raised Option Care Health from a "hold" rating to a "buy" rating in a report on Saturday, August 1st. Weiss Ratings upgraded Option Care Health from a "sell (d+)" rating to a "hold (c-)" rating in a research report on Friday, September 11th. Finally, Deutsche Bank Aktiengesellschaft restated a "hold" rating and issued a $24.00 price target (down from $26.00) on shares of Option Care Health in a research report on Thursday, July 30th.
View Our Latest Report on Option Care Health
Option Care Health Price Performance
OPCH stock opened at $22.64 on Monday. Option Care Health has a fifty-two week low of $18.01 and a fifty-two week high of $36.80. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.47 and a quick ratio of 0.98. The stock has a market capitalization of $3.39 billion, a price-to-earnings ratio of 17.02, a PEG ratio of 1.30 and a beta of 0.58. The business's fifty day moving average price is $23.58 and its two-hundred day moving average price is $23.59.
Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its earnings results on Wednesday, July 29th. The company reported $0.45 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.43 by $0.02. Option Care Health had a net margin of 3.68% and a return on equity of 18.74%. The company had revenue of $1.44 billion during the quarter, compared to analysts' expectations of $1.42 billion. During the same quarter in the previous year, the business posted $0.41 earnings per share. Option Care Health's quarterly revenue was up 1.9% on a year-over-year basis. Option Care Health has set its FY 2026 guidance at 1.850-1.920 EPS. On average, equities analysts anticipate that Option Care Health will post 1.7 earnings per share for the current year.
Hedge Funds Weigh In On Option Care Health
Several hedge funds have recently bought and sold shares of the company. Sumitomo Mitsui Trust Group Inc. bought a new position in shares of Option Care Health in the 1st quarter valued at $70,287,000. Norges Bank bought a new stake in Option Care Health during the 4th quarter worth $61,787,000. Van Berkom & Associates Inc. acquired a new position in Option Care Health in the 1st quarter worth about $42,739,000. Bank of New York Mellon Corp bought a new position in Option Care Health in the second quarter valued at about $19,600,000. Finally, Southpoint Capital Advisors LP boosted its stake in shares of Option Care Health by 20.0% during the first quarter. Southpoint Capital Advisors LP now owns 3,600,000 shares of the company's stock valued at $96,912,000 after purchasing an additional 600,000 shares in the last quarter. 98.05% of the stock is owned by institutional investors.
Option Care Health Company Profile
(
Get Free Report)
Option Care Health, Inc NASDAQ: OPCH is a provider of home and alternate-site infusion services in the United States. The company works with patients, physicians, hospitals, health plans and pharmaceutical manufacturers to deliver and manage infusion therapy outside traditional hospital settings, including in patients' homes, ambulatory infusion suites and other community-based locations.
Its services include the provision and administration of specialty medications and other infusion therapies for conditions such as infections, immune disorders, chronic diseases and nutritional deficiencies.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.